Spinal Modulation Begins Enrollment for Neurostimulator System Study

Spinal Modulation, a global medical device company, announced the first patient enrollment in its U.S. clinical trial — The ACCURATE Study, a randomized, multi-center, controlled trial that will evaluate the safety and efficacy of the Axium Neurostimulator System for the treatment of chronic lower limb pain.

Advertisement

The ACCURATE Study will enroll patients with chronic lower limb pain caused by Complex Regional Pain Syndrome or nerve damage. It is expected to enroll 152 patients in up to 25 medical centers in the U.S.

More Articles on Pain Management:

Licking Memorial Hospital Adds Dr. Sachida Manocha to Medical Staff
3 Physicians Join National Spine & Pain Center
Georgia Governor Signs Pain Clinic Regulation Bill

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.